News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Glecirasib demonstrates efficacy in KRASG12C-mutated NSCLC – ASCO
Photo from ASCO/LinkedIn
May 2, 2024, 14:30

Glecirasib demonstrates efficacy in KRASG12C-mutated NSCLC – ASCO

American Society of Clinical Oncology (ASCO) shared on X:

“Breaking news from the ASCO Plenary Series:

Glecirasib demonstrates encouraging efficacy and safety in KRASG12C-mutated Non- Small Cell Lung Cancer (NSCLC) in phase 2 trial from China.

ASCO Daily News has more.”

Glecirasib

Source: ASCO/X

American Society of Clinical Oncology ASCO ASCO Daily News cancer Glecirasib non small cell lung cancer NSCLC OncoDaily Oncology
Special Coverage
Voices
Aug 27, 2025, 08:12
Ostomy Supplies are Not One-Size-Fits-All - Fight Colorectal Cancer
Voices
Aug 27, 2025, 06:55
Arjun K Ghosh Engages in Timely Discussion on Cardio Oncology
Voices
Aug 27, 2025, 06:41
Sanjit Agrawal Reflects on the Success of ABSICON 2025
Science
Aug 27, 2025, 06:33
Alireza Mansouri Highlights a Trial on Immunotherapy in Newly Diagnosed Glioblastoma
Voices
Aug 27, 2025, 06:23
Kenyan Network of Cancer Organizations Hosts Africa Cancer Research and Control ECHO Review
Drugs
Aug 27, 2025, 06:17
Zanidatamab (Ziihera) Updates 2025: Uses in Cancer, Side Effects, Dosage, Expectations, and More
Science
Aug 27, 2025, 06:17
Robbe Heestermans Highlights cfDNA as a Tool for Liquid Biopsy in Multiple Myeloma
Opinion
Aug 27, 2025, 06:01
Omar Islam: Kicking off Breast Cancer Awareness Month with Breast AI Webinar
Voices
Aug 26, 2025, 19:43
ISLB25 Call for Research Submissions - International Society of Liquid Biopsy
Science
Aug 26, 2025, 19:35
Oscar Tahuahua: Lung Metastases - A Must-Read
Voices
Aug 26, 2025, 19:26
HT25: Tokyo Is Where Science Meets Impact - IASLC
Science
Aug 26, 2025, 19:21
Patrick Forde: A Graphic Research Summary for the CheckMate 816 Trial in NEJM